CVS Health Corp

CVS

Equity

ISIN null / Valor 548525

New York Stock Exchange, Inc (2025-11-21)

USD 78.03+2.62%

CVS Health Corp
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

CVS Health Corp is a leading healthcare company that offers a wide range of services, including pharmacy benefits management, retail pharmacy, and healthcare clinics. The company has expanded its business through strategic acquisitions, such as Coram, Omnicare, Navarro Discount Pharmacy, and Target's pharmacies and clinics. In response to the COVID-19 pandemic, CVS has played a significant role in providing testing and vaccinations, partnering with the CDC to offer on-site vaccinations at nursing homes and assisted living facilities.

Summarized from source with an LLMView SourceSector: Healthcare

Financial Performance

In the second quarter of 2025, CVS Health Corp's total revenues grew by 8.4% year-over-year to reach $98.9 billion. The GAAP diluted earnings per share (EPS) stood at $0.80, while the Adjusted EPS was reported at $1.81. The company also generated $6.5 billion in cash flow from operations for the year-to-date.

Operational Achievements

Aetna® made significant strides in care navigation, enhancing the overall healthcare experience for members. CVS Pharmacy® expanded its footprint by agreeing to acquire certain prescription files and store locations from Rite Aid, strengthening its market presence. Additionally, CVS Caremark® showcased its market-leading innovation with strong renewals and a robust sales season.

Full-Year 2025 Guidance Update

CVS Health Corp revised its full-year 2025 guidance, lowering the GAAP diluted EPS range to $3.84 to $3.94 from the previously projected $4.23 to $4.43. However, the Adjusted EPS guidance was raised to a range of $6.30 to $6.40 from $6.00 to $6.20. Furthermore, the company increased its cash flow from operations guidance to at least $7.5 billion, up from the earlier estimate of approximately $7.0 billion.

Summarized from source with an LLMView Source

Key figures

36.7%1Y

-20.3%3Y

17.5%5Y

Performance

36.9%1Y

31.5%3Y

29.3%5Y

Volatility